Tagged with S

Latam Clinical Trials While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a business unit of SIPLAS labs and was known at the time as SIPLAS Research Organization. We decided to change our name to LatAm…

Hutchison Medipharma You began your career at Pfizer, working your way up the organizational ladder, when suddenly you decided to come to China back in 2001, well before China was on the map for R&D. What drove you to make this choice, to take the risk and come to China? It wasn’t…

Herrington & Sutcliffe LLP - Hong Kong This interview was conducted with Christopher Stephens, managing partner of Orrick, Herrington & Sutcliffe’s Asia offices with supporting responses from Xiang Wang, lead partner of the firm’s IP pracitce as well as Patricia Thayer, life sciences specialist in IP litigation and counseling. Could you provide a brief introduction to Orrick,…

Merck Serono China As growth has stalled in Europe, the US and Japan, many multinational companies are looking at China as part of a hedging strategy and a key growth driver of the future. You must be feeling a lot of pressure from company headquarters as well as the natural pressures of working…

Alliance of Bio-Box Outsourcing China Could you please give a brief introduction to the ABO and its history? ABO was established in 2005. The CRO business emerged in 2000 in China, and provided services for medicine factories; however, these CRO companies were small as individuals. As a result, they were gathered together and ABO was…

China Pharmaceutical Enterprises Association First, let me briefly introduce myself. I used to work in Fuxin, a small city in the industrially advanced province of Liaoning which is equivalent to a state in the US. I worked in a company’s pharmaceutical factory for twenty years holding various positions such as technology director, factory head,…

China Association of Traditional Chinese Medi You started the Chinese operations and have been working in the country for many years but recently moved up to running all operations in Asia Pacific. Are you still closely involved with what’s happening in China? I started the operations in China almost 16 years ago, and I started them…

China Pharmaceutical Industry Association (CPIA) You have a very long history in the Chinese pharmaceutical industry, first in the joint venture company Xian-Janssen and then in the China National Pharmaceutical Group. Could you highlight the main evolutions of the Chinese pharmaceutical industry through these fast-changing times? It is indeed true that we have undergone tremendous…

China MSD China’s Michel Vounastos gives his initial impressions of the opportunities and challenges inherent in the Chinese healthcare market, and highlights how MSD’s offerings are able to address specific gaps in the country. You just arrived in China in February. The country managers we’ve met have all been here for…

Novartis Chile Novartis’ pharmaceutical activities include innovators, generics and biopharmaceuticals. How has your portfolio developed in Chile? What therapeutic areas is Novartis favoring in the Chilean context? Novartis is one of the Top 5 pharmaceutical companies at an international level. We have products in all the therapeutic areas inside the ethical pharmaceutical…

IMS Health Chile IMS was recently acquired by two investment funds, how has this affected the operations of the company and what changes did it bring in the Chilean context? So far, the acquisition has been beneficial for our Chilean operations. We expect bigger transformations to take place starting January 1st 2011, and…

Alliance of Bio-Box Outsourcing China Please introduce to our readers the general situation and driving force behind the creation of the Beijing Pharma and Biotech Center and its core mandate? Established in 1996, BPBC is an affiliated agency of the Beijing Municipal Science and Technology Commission and serves as a professional service organization for the…